[ACRS] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
08-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- 2.56%
YoY- -24.27%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 1,095 983 5,865 5,041 3,669 1,628 3,676 -55.29%
PBT -19,177 -23,138 -49,876 -37,565 -38,551 -32,740 -31,218 -27.67%
Tax -32,181 32,733 18,504 0 -958 0 1,500 -
NP -18,594 -55,319 -49,876 -37,565 -38,551 -32,740 -31,218 -29.14%
Tax Rate - - - - - - - -
Total Cost 19,689 56,302 55,741 42,606 42,220 34,368 34,894 -31.64%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin -1,698.08 -5,627.57 -850.40 -745.19 -1,050.72 -2,011.06 -849.24 58.51%
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS -0.45 -1.34 -1.21 -0.91 -0.99 -1.06 -1.01 -41.57%
EPS Diluted -0.45 -1.34 -1.21 -0.91 -0.99 -1.06 -1.01 -41.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.